Chinese newspaper The Health Times reported that recently Anhui authorities announced that medical institutions must prohibit the unauthorized import of medical products, starting from June 1, 2022.
The statement points toward public medical institutions that use financial budget funds for buying activities. The new regulation requires these institutions to submit a purchase application with an expert’s opinion. Purchases of imported products are not allowed without approval.
Health Times reported that since 2021 provinces like Zhejiang, Guangdong, Sichuan, and Shanxi have already followed the same regulation. The policy aligns with the communist party’s ‘Made in 2025’ plan. The purpose is to increase the localization of large medical equipment.
In 2021, the Chinese regime distributed new auditing guidelines on the state’s purchases of imported products. Accordingly, hundreds of medical gadgets will be procured locally at a 100 percent ratio. This has sparked industry talks regarding the second wave of domestic medical equipment substitution.
According to Apollo news, Some netizens pointed out that there’s a profit motive behind the new regulation. Many national manufacturers in this industry have ties with party officials.
Other netizens also said that the performance of domestic products is no better than imported ones. Importers mostly employ product performance and quality services to advance the market. Also, the authorities claim such policies reduce the cost of medical care for the people. However, buying that much domestic equipment will cost more in equipment inspection fees.
Back at the beginning of the pandemic, the world healthcare industry had questioned Chinese medical equipment’s quality. NBC News reported in April 2020, a group of senior British doctors said some 250 ventilators bought from China had problematic oxygen supplies. They said, quote “We believe that if used, significant patient harm, including death, is likely” end quote.